Skip to main content

MOBILE LADS CORP., Announces the Formation of a Product Advisory Board

TORONTO, ON / ACCESSWIRE / March 01, 2022 / MOBILE LADS, CORP. (OTC PINK:MOBO) is pleased to announce the appointment of Mr. Adam Tapp as Head of Product Development.

In his new position, Mr. Tapp will be working with our research partners, in the cultivation and development of leading-edge psychedelic medications to aid in the treatment of mental health ailments.

Mr. Tapp has worked for 18 years as a paramedic in London, ON. This career in street level medicine has made him acutely aware of the need for change in the treatment of mental health challenges and our perceptions of therapeutic psychedelics.

Mobile Lads welcomes Mr. Tapp's experience with these medications and his understanding of the emotional traumas they can treat.

Mobile Lads has filed a Certificate of Amendment with Nevada State name change to Avail Scientific Inc. is pending.

Contact:
Mobile Lads, Corp.
Press Relations
michael@mobilelads.com
Phone: 1.800.470.9216

Forward-Looking Statements

This release contains forward-looking statements. Forward-looking statements, without limitation, may contain the words believes, expects, anticipates, estimates, intends, plans, or similar expressions. Forward-looking statements are not guarantees of future performance. They involve risks, uncertainties and assumptions and actual results could differ materially from those anticipated. Forward looking statements are based on the opinions and estimates of management at the date the statements are made and are subject to a variety of risks and uncertainties and other factors that could cause actual events or results to differ materially from those projected in the forward-looking statements.

SOURCE: ITOCO Inc.



View source version on accesswire.com:
https://www.accesswire.com/690818/MOBILE-LADS-CORP-Announces-the-Formation-of-a-Product-Advisory-Board

Data & News supplied by www.cloudquote.io
Stock quotes supplied by Barchart
Quotes delayed at least 20 minutes.
By accessing this page, you agree to the following
Privacy Policy and Terms and Conditions.